Upcoming Events
SPEAKER: Professor Robert C. Bransfield MD, DLFAPA, DILADS
TITLE: Infection-Associated Chronic Neuropsychiatric Impairments: Exploring infectious and immune drivers of chronic cognitive, behavioural, and psychiatric symptoms
DATE: Tuesday 7th April 2026
TIME: 7:00PM BST | 8:00PM CEST | 2:00PM EDT
DESCRIPTION:
In this AONM webinar, psychiatrist Dr. Robert Bransfield explores how infections can contribute to chronic neuropsychiatric symptoms. He discusses how immune responses to pathogens can inflame the brain, impair cognition, and alter mood and behaviour.
Dr. Bransfield presents a multi-system disease model in which microbes such as Borrelia burgdorferi trigger neuroinflammation, autoimmunity, and lasting immune dysregulation. He examines how cumulative pathogen exposure may drive a spectrum of mental and behavioural disturbances.
The webinar also considers historical and modern infections, emerging research on microbes and mental illness, and potential societal impacts, including rising psychiatric burden and instability following SARS-CoV-2. It emphasises the need for a medical approach that integrates psychiatry, neurology, immunology, and infectious disease.
———————————————
ABOUT THE SPEAKERS:
PROFESSOR ROBERT C. BRANSFIELD, MD, DLFAPA, DILADS
Professor Bransfield is board certified by the American Board of Psychiatry and Neurology in Psychiatry. He is Clinical Associate Professor at Rutgers, Robert Wood Johnson Medical School, and also works in private practice. He has held teaching appointments at Hahnemann Medical College and Eastern Virginia Medical School. Dr. Bransfield has a particular interest in psychopharmacology, a unified theory of mental health and illness, the link between microbes and mental illness, Lyme and other tick-borne disease, and the link between microbes and violence.
———————————————
Register here: www.aonm.org/bransfield
SPEAKER: Professor Klaus Wirth & Patrick Ussher
TITLE: A Unifying Model of M.E.: An Integrated Approach to a Complex Illness
DATE: Tuesday 21st April 2026
TIME: 18:00 BST | 19:00 CEST | 13:00 EDT
DESCRIPTION:
Patrick Ussher, who has recently written the book “Understanding ME/CFS & Strategies for Healing”, was initially inspired by the paper written by Professors Scheibenbogen and Wirth: “A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).” He will first outline why a unifying hypothesis is likely so crucial for clarifying the nature of ME/CFS, an illness which has often been thought to involve a range of random problems but which, according to this new German research, actually involves a clear, predictable pathophysiology comprised of many interlinking vicious cycles.
Patrick will then give an overview of the main components of the Wirth and Scheibenbogen model, including: hypoperfusion, low blood volume, autoimmunity, cellular and autonomic dysfunction, and the precise reasons for post-exertional malaise.
With this overview in place, Professor Klaus Wirth will then build on the explanations of Patrick’s, outlining his disease model in much greater detail, including discussion of the therapeutic he is developing (www.mitodicure.com) which he hopes will become the first medication approved specifically for ME/CFS.
This will be a fascinating insight into this devastating condition that truly provides a unified perspective, unravelling many of its complexities.
———————————————
ABOUT THE SPEAKERS:
About Klaus Wirth
Prof. Dr. Klaus Wirth, Medical Doctor, PhD, has served as Chief Scientific Officer and Managing Director of Mitodicure since 2022. He was previously Senior Researcher at Sanofi in Germany which he joined in 1984. Klaus worked as a pharmacologist in the fields of cardiovascular, bradykinin antagonism, cerebral blood flow, stroke, heart failure, arrhythmias, sodium-calcium exchanger NCX blockers, endocrinology, diabetes, obstructive sleep apnea, dysphagia, and immunology. Approximately 70 patents are attributable to his work, as well as five clinical developmental projects, one of which Firazyr™, a drug for the treatment of acute attacks of hereditary angioedema, has reached the market. Klaus was co-founder of KOSA Pharma GmbH. He is adjunct professor at the Institute of Pharmacology at Goethe University Frankfurt, Germany.
About Patrick Ussher
Patrick Ussher is an author, composer, and ME/CFS advocate who has lived with the condition for seven years. His recent book, “Understanding ME/CFS & Strategies for Healing,” breaks down breakthrough research from Professors Wirth and Scheibenbogen for patient audiences, and he shares insights on treatment strategies through his YouTube channel (https://www.youtube.com/@me-cfs-strategiesforhealing) and writings for Health Rising.
———————————————
Register here: www.aonm.org/MEWirth
DISCLAIMER: THIS SITE DOES NOT PROVIDE MEDICAL ADVICE
The information on this webpage and these webinars is intended for educational and informative purposes only and is not intended as a substitute for medical or professional advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health care provider with regards to any questions you may have regarding a medical condition or treatment before undertaking a health care regimen. Never disregard or delay seeking professional medical advice because of information you have read or seen on this website. The opinions stated in these webinars are those of the people speaking and not necessarily of AONM.